Neuronetics (STIM)
(Real Time Quote from BATS)
$1.95 USD
+0.13 (7.14%)
Updated Jul 10, 2024 01:30 PM ET
3-Hold of 5 3
C Value F Growth F Momentum F VGM
Price, Consensus and EPS Surprise
STIM 1.95 +0.13(7.14%)
Will STIM be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for STIM based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for STIM
Neuronetics (STIM) Expands NeuroStar Portfolio With New Launch
Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates
STIM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Neuronetics' (STIM) FDA-Cleared NeuroStar to Aid in Depression
Neuronetics (STIM) Progresses in MRD and TRD With New Deal
Neuronetics (STIM) Reports Q4 Loss, Tops Revenue Estimates
Other News for STIM
BlueCross BlueShield MI and Cambia Health Solutions Expand TMS Access for Depressed Adolescents
NeuroStar Showcases Cutting-Edge Research at Clinical TMS Society Annual Meeting
Neuronetics announces participation at CTMSS
Director Robert Cascella Acquires 50,000 Shares of Neuronetics Inc (STIM)
Neuronetics And 3 Other Stocks Under $3 Insiders Are Buying